摘要
目前冠状动脉支架置入术后一年内需要行非心脏手术者数量不断增多,非心脏手术为停用抗血小板治疗的一个重要原因。术前停用抗血小板治疗增加围手术期支架内血栓形成、心肌缺血,甚至心肌梗死等心血管事件风险,如果继续给予抗血小板治疗却增加围手术期出血风险。通过对比非心脏手术围手术期停用或继续给予抗血小板治疗的相关研究结果,就制定围手术期对患者处理的有效策略做如下综述。
The number of patients who require noncardiac surgery( NCS) within the first year after percutaneous coronary intervention( PCI) is increasing,and NCS is one of the most important reason for premature discontinuation of antiplatelet therapy,which may,in turn,increase the risk of perioperative ischemic events,particularly stent thrombosis,even myocardial infarction. Its continuation may increase the risk of perioperative bleeding. We review the outcome of the trials by comparing discontinuation of antiplatelet therapy with its continuation in perioperative period patients,and describe potentially useful strategies to manage them.
出处
《心血管病学进展》
CAS
2015年第4期413-417,共5页
Advances in Cardiovascular Diseases
基金
自治区重点实验室专项资金资助项目(2012KL011)